Related Experiment Video

Updated: Jun 4, 2026

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System
05:45

In Vitro Establishment of a Genetically Engineered Murine Head and Neck Cancer Cell Line using an Adeno-Associated Virus-Cas9 System

Published on: January 9, 2020

Suicide gene therapy in head and neck carcinoma cells: an in vitro study

Marianne Schmidt1, Petra Gruensfelder, Jeanette Roller

  • 1Department of Otorhinolaryngology, University of Wuerzburg, Josef-Schneider-Strasse 11, Würzburg, Germany. schmidt_m2@klinik.uni-wuerzburg.de

International Journal of Molecular Medicine
|February 10, 2011
PubMed

Insights

The mifepristone-inducible GeneSwitch system precisely controlled Pseudomonas exotoxin A expression in head and neck cancer cells. This gene therapy approach shows promise for treating hypopharyngeal carcinoma.

Area of Science:

  • Molecular Biology
  • Gene Therapy
  • Oncology

Background:

  • Gene therapy aims for precise control of therapeutic gene expression.
  • Externally inducible gene promoters are crucial for regulating suicide genes.
  • Head and neck cancers require targeted therapeutic strategies.

Purpose of the Study:

  • To evaluate the mifepristone-dependent GeneSwitch system for controlling Pseudomonas exotoxin A (ETA) expression.
  • To assess the efficacy of the GeneSwitch-ETA combination in FADU hypopharyngeal carcinoma cells.
  • To determine the feasibility of this system for head and neck cancer gene therapy.

Main Methods:

  • Utilized the GeneSwitch system (pSwitch and pGene/V5-His-ETA plasmids).
  • Stably transfected FADU cells with pSwitch, followed by transient transfection with pGene/V5-His-ETA.
  • Assessed induction, background expression, and re-induction capacities in vitro.

Main Results:

  • The GeneSwitch-ETA system demonstrated precise and effective regulation of ETA expression in FADU cells.
  • Successful induction was observed without antibiotic selection pressure.
  • The system showed reliable inductive capacity after re-induction.

Conclusions:

  • The GeneSwitch system provides effective spatial and temporal control of transgenic expression.
  • The combination of suicide toxin genes with the GeneSwitch system is a promising strategy for head and neck cancer gene therapy.
  • Further in vitro studies support the potential of this approach for clinical application.

More Related Videos

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity07:52

In Vivo CRISPR/Cas9 Screening to Simultaneously Evaluate Gene Function in Mouse Skin and Oral Cavity

Published on: November 2, 2020

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...